SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document
 

 

 

respect to any Health Care Permit or Registration,

 

(e)       any allegations of licensure violations or fraudulent acts or omissions involving any Loan Party or any of its Subsidiaries,

 

(f)       the pending or threatened imposition of any material fine or penalty by any Governmental Authority under any Health Care Law against any Loan Party or any of its Subsidiaries, and

 

(g)        the exclusion or debarment from any Governmental Drug Rebate Program or other federal healthcare program or debarment or disqualification by any Governmental Authority of any Loan Party, any of its Subsidiaries, or any of their officers, directors, employees, agents, or contractors.

   
at least five (5) Business Days in advance of the termination of any Sale Agreement, (a) written notice of the termination of such Sale Agreement.
   
promptly, but in any event within 5 days of Borrower providing or receiving, as applicable,

(a)        copies of all settlement agreements entered into by a Loan Party or any of its Subsidiaries,

 

(b)       any notice received by a Loan Party or any of its Subsidiaries alleging potential or actual violations of any Health Care Law,

 

(c)       any notice that any Regulatory Authority is limiting, suspending or revoking any Registration, requiring adverse changes to the marketing classification, distribution pathway or parameters, or labeling of the products of any Loan Party or any of its Subsidiaries, or considering any of the foregoing,

 

(d) any notice, including, but not limited to, a Form FDA-483, untitled letter, warning letter, or notice of violation letter, that any Loan Party or any of its Subsidiaries has become subject to any Regulatory Action, and

 

(e)       any notice that any Product of any Loan Party or any of its Subsidiaries has been seized, withdrawn, recalled, detained, or subject to a suspension of manufacturing, or the commencement of any proceedings seeking the withdrawal, recall, suspension, import detention, or seizure of any Product are pending or threatened against any Loan Party or any of its Subsidiaries.

   

Promptly, but in any

event within 15 days

after the same are

required to be filed with

the SEC,

 

(a)        form 10-K annual reports, and

 

(b)        form 10-Q quarterly reports.

 

promptly after the commencement thereof or any material development (a) notice of the commencement or any material development in all actions, suits, or proceedings brought by or against Borrower or any of its Subsidiaries before any Governmental Authority (i) alleging a potential or

 

 

Schedule 5.1

Page - 2